𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome

✍ Scribed by James H. Asher Jr.; Annemarie Sommer; Robert Morell; Thomas B. Friedman


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
601 KB
Volume
7
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Semmzu

Craniofacial-deafnesshand syndrome (MIM 122880) is inherited as an autosomal dominant mutation characterized by the absence or hypoplasia of the nasal bones, profound sensorineural deafness, a small and short nose with slitlike nares, hypertelorism, short palpebral fissures, and limited movement at the wrist and ulnar deviations of the fingers. In a family of three affected individuals with this syndrome, a mother and two children, a missense mutation (Asn47Lys) in the paired domain of PAX3 was initially detected by SSCP analysis. PCR amplification using an oligonucleotide with a terminal 3'residue match for the C-to-G transversion in codon 47 showed the presence of this mutation in the DNA from all affected members. The DNA from unaffected members were refractory to PCR amplification with the mutation-specific oligonucleotide but did amplify a control primer pair in the same PCR reaction tube. A previously described missense mutation in this same codon (Asn47His) is associated with Waardenburg syndrome type 3 (Hoth et al., 1993). Substitution of a basic amino acid for asparagine at residue 47, conserved in all known murine Par and human PAX genes, appears to have a more drastic effect on the phenotype than missense, frameshift and deletion mutations of PAX3 that cause Waardenburg syndrome type 1. Q 1996 WiIey-Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Missense mutation R1066C in the second t
✍ T Casals; P Pacheco; C Barreto; J GimΓ©nez; MD Ramos; S Pereira; JA Pinheiro; N C πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

We report the clinical features of 21 unrelated cystic fibrosis (CF) patients from Portugal and Spain, who carry the mutation R1066C in the CFTR gene. The current age of the patients was higher in the R1066C/any mutation group (P < 0.01), as compared to the aF508/aF508 group. Poor values for lung ra